NASDAQ:DMRA | Cash Flow Statement | Damora Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$31.17M
2026-03-31-$27.78M-$20.6M$295.92M
2025-12-31-$200.74M$566,000.00
2025-09-30-$3.13M
2025-06-30-$3.44M
2025-03-31-$2.53M-$2.44M
2024-12-31-$6.74M-$4.94M$0.00
2024-09-30-$3.88M
2024-06-30-$5.34M
2024-03-31-$5.48M-$5.94M$5.65M
2023-12-31-$6.48M-$11.47M$9.58M$0.00
2023-09-30-$8.14M
2023-06-30-$10.74M
2023-03-31-$12.99M-$9.13M$1.37M$23,000.00
2022-12-31-$14.07M-$11.45M$41,000.00$14.33M$65,000.00
2022-09-30-$13.73M
2022-06-30-$16.89M
2022-03-31-$16.94M-$6.8M$43,000.00-$10.21M
2021-12-31-$13.41M-$17.83M-$4,000.00$14.41M
2021-09-30-$12.7M
2021-06-30-$12.3M
2021-03-31-$13.35M-$14.15M$65,000.00-$74.63M
2020-12-31-$11.58M-$14.52M$91.79M
2020-09-30-$11.65M
2020-06-30-$5.94M
2020-03-31-$5.67M-$7.98M$39.67M
2019-12-31-$24.42M-$5.25M
2019-09-30-$4.11M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$209.84M-$6.73M-$17.37M$266.84M
2024-12-31-$21.44M-$18.62M$11.65M
2023-12-31-$38.35M-$36.91M$22.33M$2.88M
2022-12-31-$61.62M-$42.93M$196,000.00$12.38M$507,000.00
2021-12-31-$51.75M-$52.31M$223,000.00-$48.05M
2020-12-31-$34.84M-$38.2M$187.39M
2019-12-31-$36.51M-$19.33M-$326,000.00